Dizal Jiangsu Pharmaceutical Co Ltd (688192)

Currency in CNY
85.21
+2.84(+3.45%)
Closed·
688192 Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Trading near 52-week High
688192 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
81.4685.95
52 wk Range
32.7285.95
Key Statistics
Bid/Ask
85.20 / 85.21
Prev. Close
82.37
Open
82
Day's Range
81.46-85.95
52 wk Range
32.72-85.95
Volume
3.4M
Average Volume (3m)
3.63M
1-Year Change
119.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688192 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.14
Downside
-5.95%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Dizal Jiangsu Pharmaceutical Co Ltd Company Profile

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases. It develops JAUKPO, which is in Phase II clinical trials for the treatment of hematological malignancy and immunological diseases; DZD8586 that is in Phase I for the treatment of hematological malignancy; ZEGFROVY, which is in Phase II clinical trials for the treatment of solid tumors; DZD1516 that is in Phase II clinical trials for the treatment of solid tumors; and DZD2269, which is in Phase I clinical trials for the treatment of solid tumors. The company was founded in 2017 and is based in Shanghai, China.

Employees
852
Market
China

Compare 688192 to Peers and Sector

Metrics to compare
688192
Peers
Sector
Relationship
P/E Ratio
−48.1x−13.9x−0.5x
PEG Ratio
−1.810.350.00
Price/Book
2,120.6x7.1x2.6x
Price / LTM Sales
89.3x23.4x3.3x
Upside (Analyst Target)
−10.8%−2.3%40.3%
Fair Value Upside
Unlock−20.1%5.1%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 80.14
(-5.95% Downside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.46 / --
Revenue / Forecast
159.64M / --
EPS Revisions
Last 90 days

688192 Income Statement

FAQ

What Stock Exchange Does Dizal Jiangsu Pharmaceutical Trade On?

Dizal Jiangsu Pharmaceutical is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Dizal Jiangsu Pharmaceutical?

The stock symbol for Dizal Jiangsu Pharmaceutical is "688192."

What Is the Dizal Jiangsu Pharmaceutical Market Cap?

As of today, Dizal Jiangsu Pharmaceutical market cap is 39.15B.

What Is Dizal Jiangsu Pharmaceutical's Earnings Per Share (TTM)?

The Dizal Jiangsu Pharmaceutical EPS (TTM) is -1.96.

When Is the Next Dizal Jiangsu Pharmaceutical Earnings Date?

Dizal Jiangsu Pharmaceutical will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 688192 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Dizal Jiangsu Pharmaceutical Stock Split?

Dizal Jiangsu Pharmaceutical has split 0 times.

How Many Employees Does Dizal Jiangsu Pharmaceutical Have?

Dizal Jiangsu Pharmaceutical has 852 employees.

What is the current trading status of Dizal Jiangsu Pharmaceutical (688192)?

As of 16 Aug 2025, Dizal Jiangsu Pharmaceutical (688192) is trading at a price of 85.21, with a previous close of 82.37. The stock has fluctuated within a day range of 81.46 to 85.95, while its 52-week range spans from 32.72 to 85.95.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.